Cibula, David; Zikan, Michal; Dusek, Ladislav; Majek, Ondrej (August 2011). «Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis». Expert Review of Anticancer Therapy11 (8): 1197–1207. doi:10.1586/era.11.38. PMID21916573.
Stadler, ZK.; Kauff, ND. (Jan 2010). «Weighing options for cancer risk reduction in carriers of BRCA1 and BRCA2 mutations.». J Clin Oncol28 (2): 189–91. doi:10.1200/JCO.2009.25.6875. PMID19996025.
Fishman A (October 2010). «The effects of parity, breastfeeding, and infertility treatment on the risk of hereditary breast and ovarian cancer: a review». Int. J. Gynecol. Cancer20 (11 Suppl 2): S31–3. doi:10.1111/IGC.0b013e3181f60d4d. PMID20975359.
King, MC; Marks, JH; Mandell, JB (Oct 2003). «Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.». Science302 (5645): 643–6. doi:10.1126/science.1088759. PMID14576434.
Pal T, Keefe D, Sun P, Narod SA (April 2010). «Fertility in women with BRCA mutations: a case-control study». Fertil. Steril.93 (6): 1805–8. doi:10.1016/j.fertnstert.2008.12.052. PMID19200971.
Moslehi, R; Singh, R; Lessner, L; Friedman, JM (March–April 2010). «Impact of BRCA mutations on female fertility and offspring sex ratio.». Am J Hum Biol22 (2): 201–5. doi:10.1002/ajhb.20978. PMID19642207.
Kotsopoulos J, Lubisnki J, Salmena L, et al. (March 2012). «Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers». Breast Cancer Res14 (2): R42. doi:10.1186/bcr3138. PMID22405187. Lay summary – The Telegraph (29 March 2012).
Cibula, David; Zikan, Michal; Dusek, Ladislav; Majek, Ondrej (August 2011). «Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis». Expert Review of Anticancer Therapy11 (8): 1197–1207. doi:10.1586/era.11.38. PMID21916573.
Stadler, ZK.; Kauff, ND. (Jan 2010). «Weighing options for cancer risk reduction in carriers of BRCA1 and BRCA2 mutations.». J Clin Oncol28 (2): 189–91. doi:10.1200/JCO.2009.25.6875. PMID19996025.
Fishman A (October 2010). «The effects of parity, breastfeeding, and infertility treatment on the risk of hereditary breast and ovarian cancer: a review». Int. J. Gynecol. Cancer20 (11 Suppl 2): S31–3. doi:10.1111/IGC.0b013e3181f60d4d. PMID20975359.
King, MC; Marks, JH; Mandell, JB (Oct 2003). «Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.». Science302 (5645): 643–6. doi:10.1126/science.1088759. PMID14576434.
Pal T, Keefe D, Sun P, Narod SA (April 2010). «Fertility in women with BRCA mutations: a case-control study». Fertil. Steril.93 (6): 1805–8. doi:10.1016/j.fertnstert.2008.12.052. PMID19200971.
Moslehi, R; Singh, R; Lessner, L; Friedman, JM (March–April 2010). «Impact of BRCA mutations on female fertility and offspring sex ratio.». Am J Hum Biol22 (2): 201–5. doi:10.1002/ajhb.20978. PMID19642207.
Kotsopoulos J, Lubisnki J, Salmena L, et al. (March 2012). «Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers». Breast Cancer Res14 (2): R42. doi:10.1186/bcr3138. PMID22405187. Lay summary – The Telegraph (29 March 2012).
Kotsopoulos J, Lubisnki J, Salmena L, et al. (March 2012). «Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers». Breast Cancer Res14 (2): R42. doi:10.1186/bcr3138. PMID22405187. Lay summary – The Telegraph (29 March 2012).